Dextromethorphan – Effects, Dosage & Side Effects

What is Dextromethorphan?

Dextromethorphan (commonly abbreviated as DXM) is a synthetically produced active substance belonging to the class of antitussives, meaning cough-suppressing agents. It is found in numerous over-the-counter cough and cold preparations and is one of the most widely used cough suppressants worldwide. Chemically, dextromethorphan is a morphinan derivative; however, unlike opioid analgesics, it does not relieve pain and does not carry a significant risk of addiction when used as directed.

Mechanism of Action

Dextromethorphan acts primarily as an NMDA receptor antagonist (N-methyl-D-aspartate receptor) in the central nervous system. By blocking these receptors, it inhibits the cough center located in the medulla oblongata (brainstem), thereby suppressing the cough reflex. It also binds to sigma-1 receptors and blocks certain serotonin transporters, which further shapes its pharmacological profile.

Unlike codeine, dextromethorphan does not act on opioid receptors. As a result, it has no analgesic (pain-relieving) effect and does not cause respiratory depression at therapeutic doses.

Indications

Dextromethorphan is primarily used for the symptomatic relief of dry, irritating coughs, particularly in the context of:

• Dry, unproductive coughs associated with colds and upper respiratory infections
• Persistent cough following respiratory tract infections
• Cough that significantly disrupts sleep or daily activities

It is not suitable for productive coughs with mucus, as expelling the mucus through coughing is beneficial in those cases.

Dosage and Forms

Dextromethorphan is available in various formulations:

• Cough syrup (oral solution)
• Lozenges
• Hard capsules
• Combination products (e.g., with guaifenesin or antihistamines)

The standard adult dose is 10–30 mg every 4–8 hours, not exceeding 120 mg per day. For children, dosing depends on weight and age. Dextromethorphan should not be given to children under 2 years of age. Use in children aged 6 and older may be appropriate under medical supervision.

Side Effects

When used as directed, dextromethorphan is generally well tolerated. Possible side effects include:

• Dizziness and lightheadedness
• Nausea and gastrointestinal discomfort
• Sedation (drowsiness)
• Skin rash (rare)

At high doses or in overdose, dextromethorphan can produce psychoactive effects such as dissociation and hallucinations, which is why it is occasionally misused. Overdose is a medical emergency and requires immediate medical attention.

Drug Interactions

Significant interactions have been observed with:

• MAO inhibitors: Concurrent use can lead to a potentially life-threatening serotonin syndrome. MAO inhibitors must not be taken at the same time as or within 14 days of stopping dextromethorphan.
• Serotonergic drugs (e.g., certain antidepressants): Increased risk of serotonin syndrome.
• CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): These can slow the metabolism of dextromethorphan, leading to elevated plasma concentrations.

Contraindications

Dextromethorphan should not be used in cases of:

• Concurrent use of MAO inhibitors
• Known hypersensitivity to the active substance
• Productive cough with mucus secretion
• Bronchial asthma or COPD (chronic obstructive pulmonary disease) without medical advice
• Children under 2 years of age

Pregnancy and Breastfeeding

The use of dextromethorphan during pregnancy should only be considered after careful benefit-risk assessment and medical recommendation, as the available safety data during pregnancy are limited. During breastfeeding, caution is advised, as the substance may pass into breast milk.

References

1. Brayfield A (ed.) - Martindale: The Complete Drug Reference, 38th edition, Pharmaceutical Press, London, 2014.
2. European Medicines Agency (EMA) - Assessment report on dextromethorphan-containing medicinal products, 2015. Available at: www.ema.europa.eu
3. Brunton L, Hilal-Dandan R, Knollmann B - Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13th edition, McGraw-Hill Education, New York, 2018.